Data-driven tiered procedure for enhancing yield in drug product manufacturing
Journal article, 2016

Enhancing efficiency of pharmaceutical batch production processes is an important challenge in times of increasing public pressure on healthcare costs and decreasing research productivity. This study presents a data-based procedure for systematic yield enhancements in drug product manufacturing, based on four steps. On the first step, production is reviewed to select relevant loss causes, which are assessed on the second step deductively with the goal of assigning measurable parameters. Descriptive Statistical Modelling of loss causes is then performed on the third step, enabling model-based enhancements of processes on the fourth step or, if necessary, a loop-back review of a given loss cause. An industrial case study was performed on production data of 88 batches and demonstrated the applicability of the procedure by prioritizing relevant loss causes, reducing required sample quantities by up to 8% and a cosmetic defect by about 70% by a process change.

Sterile drug product manufacturing

Industrial case study

Decision-making

Multivariate data analysis

Biologics

Author

L. Eberle

F. Hoffmann-La Roche AG

ETH Zurich

H. Sugiyama

University of Tokyo

Stavros Papadokonstantakis

Chalmers, Energy and Environment, Industrial Energy Systems and Technologies

A. Graser

F. Hoffmann-La Roche AG

R. Schmidt

F. Hoffmann-La Roche AG

K. Hungerbühler

ETH Zurich

Computers and Chemical Engineering

0098-1354 (ISSN)

Vol. 87 82-94

Areas of Advance

Production

Life Science Engineering (2010-2018)

Subject Categories (SSIF 2011)

Chemical Engineering

DOI

10.1016/j.compchemeng.2015.12.012

More information

Created

10/7/2017